Documentos relacionados

1. Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for "clean blood pool" imaging.
2. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc^99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study.
3. Volumetric evaluation of ^99mTc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.
4. Inter-observer reproducibility and intra-observer repeatability in ^99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis.
5. Transthyretin amyloid cardiomyopathy disease burden quantified using ^99mTc-pyrophosphate SPECT/CT: volumetric parameters versus SUVmax ratio at 1 and 3 hours.
6. Diagnostic value of heart-to-mediastinum ratio in ^99mTc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis.
7. A case of disappearing amyloid on technetium pyrophosphate scan.
8. Use of SPECT imaging to confirm ATTR cardiac amyloid in a Tc99m pyrophosphate study artefactually compromised by a recent V/Q scan.
9. Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
10. Echocardiographic score for the screening of cardiac amyloidosis with positive 99m technetium pyrophosphate scintigraphy result.